The American Geriatrics Society has released its 2023 revision of the Beers Criteria with detailed discussions of anticoagulant use in adults aged 65 years or
FDA yesterday approved the respiratory syncytial virus vaccine, adjuvanted (Arexvy, GlaxoSmithKline Biologicals) for the prevention of lower respiratory tract disease (LRTD) caused by RSV in
In a retrospective cohort study, U.S. nursing home residents had higher rates of hypoglycemic events following the initiation of glimepiride and with standard doses of
In the RENOIR trial, an investigational bivalent respiratory syncytial virus (RSV) prefusion F protein–based (RSVpreF) vaccine “prevented RSV-associated lower respiratory tract illness and RSV-associated acute
Fee-for-service Medicare beneficiaries with self-reported functional impairments and phenotypic frailty had higher subsequent healthcare costs, a prospective cohort study shows. The differences remained even after
In 2017, the use of benzodiazepines and antipsychotic agents differed markedly among 1.4 million hospice-enrolled Medicare beneficiaries aged 65 years or older across factors other than
Among Ontario nursing home residents, concomitant use of benzodiazepines (BZDs) or gabapentinoids with opioids continues, but different patterns of co-use are appearing, a study shows.
Despite recommendations for high-intensity statins following ischemic strokes or transient ischemic attacks (TIAs), data from the Comprehensive Post-Acute Stroke Services (COMPASS) Study show disparate prescribing
In the Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (OPTIMUM) trial, outcomes were better when current antidepressants were augmented with aripiprazole rather than discontinued
A multifaceted antibiotic stewardship intervention safely reduced antibiotic prescribing for suspected urinary tract infections in frail older adults, the ImpresU trial shows. In Poland, the